Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Emerging Function of N6-Methyladenosine and Its Regulators in Endometrial Cancer; Current Knowledge and Prospect Publisher



Rabiei M1 ; Ghalandarpoorattar SM2 ; Ghalandarpoorattar SN3 ; Nurzadeh M4
Authors

Source: Human Gene Published:2023


Abstract

N6-methyladenosine (m6A) is an epigenetic modification of RNA that was first discovered in mRNA in the 1970s. The principal contributors to RNA methylation modification are methyltransferases, demethylases, and binding proteins. M6A as the most studied RNA modification is crucial to the onset and progression of a wide range of diseases, including malignant tumors. This particular posttranscriptional alteration of RNA is both dynamic and reversible, and it controls several aspects of RNA metabolism in eucaryons such as translation, exporting, splicing, decay, and processing. One of the three most common forms of cancer in women's reproductive organs, endometrial cancer (EC) is a devastating disease. The involvement of m6A regulators in a wide variety of EC activities has been the subject of a large number of investigations. In this study, we focus on the underlying mechanisms of m6A alterations in EC and further discuss the prospective therapeutic targets linked with m6A regulators that might be used in the treatment of cancer. © 2023 Elsevier B.V.
Related Docs
View other Related Docs
1. Unraveling the Complex Interactions Between the Fat Mass and Obesity-Associated (Fto) Gene, Lifestyle, and Cancer, Advances in Nutrition (2022)
2. N6-Methyladenosine (M6a) Rna Modification’S Regulatory Role in Acute and Chronic Leukemia, Gene Expression The Journal of Liver Research (2025)
3. The Sequestosome 1 Protein: Therapeutic Vulnerabilities in Ovarian Cancer, Clinical and Translational Oncology (2023)
Experts (# of related papers)
View all Related Experts
Maryam Noorzadeh (2)
Maryam Rabiei (2)
Other Related Docs
4. Curcumin Anti‐Tumor Effects on Endometrial Cancer With Focus on Its Molecular Targets, Cancer Cell International (2021)
5. Micrornas, Long Non-Coding Rnas, and Circular Rnas and Gynecological Cancers: Focus on Metastasis, Frontiers in Oncology (2023)
6. Microrna-26B Reduces Cell Viability by Inhibition of Nicotinamide Phosphoribosyltransferase in Breast Cancer Cells, DNA and Cell Biology (2022)
7. Functions, Mechanisms, and Clinical Applications of Lncrna Linc00857 in Cancer Pathogenesis, Human Cell (2023)
8. The Homeostasis and Therapeutic Applications of Innate and Adaptive Immune Cells in Periodontitis, Oral Diseases (2023)
9. Potential Roles of Hsa_Circ_000839 and Hsa_Circ_0005986 in Breast Cancer, Journal of Clinical Laboratory Analysis (2022)
10. Epi-Drugs and Epi-Mirs: Moving Beyond Current Cancer Therapies, Current Cancer Drug Targets (2016)
11. Regulation and Function of Microrna-152 in Various Types of Cancers: Its Upstream Regulators and Downstream Targets, Clinical and Experimental Medicine (2025)
12. The Role of Interferon (Ifn)-Γ in Extravillous Trophoblast Cell (Evt) Invasion and Preeclampsia Progression, Reproductive Sciences (2023)
13. Competing Endogenous Rna (Cerna) Cross Talk and Language in Cerna Regulatory Networks: A New Look at Hallmarks of Breast Cancer, Journal of Cellular Physiology (2019)
14. Long Non-Coding Rna Snhg6 As a Potential Biomarker for Hepatocellular Carcinoma, Pathology and Oncology Research (2018)
15. Reciprocal Interconnection of Mirnome-Epigenome in Cancer Pathogenesis and Its Therapeutic Potential, Epigenetics Territory and Cancer (2015)
16. Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review, Cancers (2023)
17. The Role of Long Noncoding Rnas (Lncrnas) in the Pathogenesis of Chemoresistance in Endometrial Cancer: A Molecular Approach and Future Perspective, Indian Journal of Gynecologic Oncology (2025)
18. Micrornas-Mediated Regulation Pathways in Rheumatic Diseases, Inflammopharmacology (2023)
19. The Role of Mirnas 340-5P, 92A-3P, and 381-3P in Patients With Endometriosis: A Plasma and Mesenchymal Stem-Like Cell Study, BioMed Research International (2021)
20. Investigating the Expressions of Mirna-125B and Tp53 in Endometriosis. Does It Underlie Cancer-Like Features of Endometriosis? a Case-Control Study, International Journal of Reproductive BioMedicine (2020)